1 January 2020 in Respiratory Medicine Case Reports
Objectives: Nocardiosis is a rare infection caused by Nocardia spp., a gram-positive bacteria non-commensal of the human flora. Nocardiosis usually presents with lung infection but may disseminate to other organs, most frequently the brain. The major risk factor is immunosuppression, but lung diseases also increase the risk of infection. Treatment with antibiotics is usually prolonged. In this study, we made a retrospective analysis of pulmonary nocardiosis cases and a review of the available literature. Methods: We made a retrospective analysis of all pulmonary nocardiosis cases from 13 years (January 2005 to December 2017) in our institution, selecting patients from pulmonology and infectious diseases consultation. Results: We found four patients diagnosed with pulmonary nocardiosis, three males (patients 1, 2 and 3) and one female (patient 4). Median age was 71. 15 years old. Different specimens were identified (N. cyriacigeorgica, Nocardia spp., N. nova, and N. wallacei/transvalensis). Bronchofibroscopy with bronchoalveolar lavage culture was the most frequent diagnostic procedure (patients 1 and 4). Only patient 2 presented an unfavorable response to treatment and died from septic shock. Conclusions: Pulmonary nocardiosis has a good prognosis if diagnosed early and treated adequately. It should always be considered in the differential diagnosis of pulmonary infections concomitant with brain or other soft tissue lesion, especially in immunocompromised patients.
18 October 2024 in Respiratory Medicine
22 December 2025 in Pulmonology
Background: The use of home mechanical ventilation (HMV) has been increasing worldwide, driven by widening of clinical applications and improved patient survival rates. In Portugal, recent data indicate an even faster growth, although national HMV recommendations have remained unchanged for 25 years. Research question: We aimed to provide an update in clinical practice guidelines for HMV in adults, applicable to the Portuguese context, grounded on the latest available evidence and experts' opinion. Study design and methods: A multidisciplinary panel with experience in HMV in the adult population was assembled. A comprehensive literature search was conducted during March 2023 regarding specific topics: equipment, ventilatory modes and interfaces, HMV initiation, follow-up and monitoring, disease specificities (neuromuscular diseases, obesity-hypoventilation syndrome, restrictive chest wall diseases; chronic obstructive pulmonary disease, and other diseases), home mechanical invasive ventilation, and palliative and end of life care. A 2-round Delphi process was conducted to establish consensus among panel members. A minimum agreement threshold of 80% was required. Results: Out of 88 recommendations initially included in the Delphi process, 61 were selected by consensus. Conclusion: Final recommendations grounded in the current level of evidence are outlined, and the key limitations and proposals for future research are discussed.
23 October 2025 in ERJ Open Research
Background and objectives: Home respiratory therapies, including long-term oxygen therapy (LTOT) and home mechanical ventilation (HMV), are essential for patients with chronic respiratory diseases, yet their effectiveness depends on uninterrupted electricity. However, the preparedness of healthcare systems for large-scale blackouts remains largely unexplored. The aim of the study was to evaluate the preparedness of healthcare centres in the Iberian Peninsula to manage patients who are dependent on home respiratory therapies during blackouts, evaluate the clinical impact of the April 2025 power outage, and identify areas for improvement. Methods: Cross-sectional online survey among pulmonologists in Spain and Portugal, assessing protocols, patient identification systems, emergency responses and the clinical impact of the blackout. Results: 60 centres participated (Spain n=39; Portugal n=21), each covering a median population of 350 000 inhabitants. 35% of centres had all three preparedness components: formal protocols, systematic patient identification and active registries of home respiratory therapies patients at risk. During the blackout, 44.8% of centres did not contact patients; those that did mainly used respiratory homecare providers (43.1%) as intermediaries. Emergency services were the primary source of support (80.4%). Hospital visits were reported in 55.9% of centres for LTOT patients and 50% for HMV patients, although most cases did not require hospitalisation. Multivariate analysis showed that formal protocols were the only factor associated with higher preparedness (β=3.36; p<0.001). Conclusions: The blackout exposed critical gaps in emergency preparedness for patients dependent on home respiratory therapies. Ensuring updated patient registries, strengthening formal protocols, and cross-sector coordination are essential to safeguard vulnerable populations during power disruptions.